Healthcare -
Biotechnology - NASDAQ - US
$ 14.69
3.89 %
$ 1.49 B
Market Cap
-4.1
P/E
DYN - ACCOUNTS PAYABLE
Accounts Payable DYN - Dyne Therapeutics, Inc.
22.9 M
LAST VALUE
138.54%
2 YEAR CAGR
113.42%
5 YEAR CAGR
-23.38%
10 YEAR CAGR